Search results
Results from the WOW.Com Content Network
“The nation’s largest nursing home pharmacy, Omnicare Inc. of Covington, Kentucky, will pay $98 million,” Assistant Attorney General Tony West announced, to settle charges that it “solicited and received kickbacks from a pharmaceutical manufacturer, Johnson & Johnson (J&J), in exchange for agreeing to recommend that physicians prescribe Risperdal, a J&J antipsychotic drug, to nursing ...
Personal injury lawyers were piling on, too, using websites, Google search advertising, social media and TV ads to gather clients who could claim they had been injured by Risperdal—and in some cases the competitor drugs sold by Eli Lilly or AstraZeneca. (Their Google ads are still there; search “Risperdal lawsuits.”
The Pledger trial had begun in Philadelphia on the afternoon of Friday, January 23, 2015. The plaintiff and her lawyers were now facing off against Diane Sullivan, a partner at Weil, Gotshal & Manges, a 1,100-lawyer Wall Street firm. At a firm known for tough lawyers, Sullivan has a reputation as one of the toughest.
Most notably, he was included in Best Lawyers in America from 2017 to 2021. [32] He was also ranked as one of the “Top 100 Trial Lawyers in America,” in the 2019 and 2020 editions of Benchmark Litigation, in addition to being recognized as a “Texas Litigation Star” and “National Practice Area Star” in General Commercial Litigation. [33]
Risperdal, Invega, Nesiritide: False Claims Act, FDCA 2012 Abbott Laboratories [8] $1.5 billion Off-label promotion Depakote: False Claims Act, FDCA 2009 Eli Lilly [9] $1.4 billion Off-label promotion Zyprexa: False Claims Act, FDCA 2001 TAP Pharmaceutical Products [10] $875 million Medicare fraud, kickbacks Lupron
Compounding the problem for J&J’s business strategists, the FDA’s December 29, 1993, letter officially approving the sale of Risperdal warned that the agency would “consider any advertisement or promotional labeling for Risperdal false, misleading or lacking fair balance” if it stated or implied that “Risperdal is superior to ...
Franklin and his attorney, Thomas M. Greene, filed a lawsuit, Franklin v. Parke-Davis, under the False Claims Act in federal district court in Boston. In the first off-label promotion case ever litigated in a whistleblower suit under the False Claims Act, the settlement was announced after eight years of litigation in May 2004.
By the end of 2003, Jones ended up with Thomas Melsheimer, a well-known Dallas trial lawyer at the firm Fish & Richardson. Melsheimer had won big verdicts for defendants, as well as plaintiffs, in cases ranging from antitrust to insider trading to bank fraud. Melsheimer set his sights on recruiting a key partner: Texas Attorney General Greg Abbott.